Batman: Toxic Chill is an action-adventure computer game about DC Comics Batman comic book superhero, created by ImaginEngine Corp. .
| Batman: Toxic Chill | |
|---|---|
| Developers | ImaginEngine Corp. |
| Publisher | The Learning Company, Inc. |
| Release dates | September 2003 [1] |
| Genre | Action adventure |
| Age rating | ESRB : E -Everyone |
| Technical details | |
| Platforms | Hybrid PC / Mac |
| Game mode | single user |
| Carriers | CD-ROM |
| Control | keyboard mouse |
Content
Gameplay
Batman will have to challenge the ruthless criminals on the streets of Gotham City, for example, destroy the plans of the cold-blooded Mr. Freeze and stop Riddler. In this Great detective, his faithful partner Robin will help. The player is awaited by various logic puzzles and puzzles.
Story
Mr. Freeze and the Riddler said they want to freeze Gotham . Frieze reported freezing Gotham. Batman and Robin are heading to Gotham, and the buildings are already frozen by Freeze. They managed to unfreeze buildings with the device, save people and find a clue, but Frieze managed to hide. Batman and Robin and Batgirl managed to combine liquid and snow into a capsule and it exploded [ ambiguous ] . Batman enters the dungeon under the Coventri Lab and eavesdrops on the dialogue of Mr. Freeze and Ridler. Penetrating once more into the dungeon, Batman understood the villains plan. After solving the riddle puzzle, Batman and Robin flew to Bet to save Gotham. With the help of Bat, Batman and Robin managed to save Gotham and put Elizabeth Arkham in the hospital for the insane criminals Mr. Freeze and the Riddler.
Characters
- Batman Gotham's defender.
- Robin Batman's assistant.
- Commissioner James Gordon . Gotham Police Commissioner.
Villains
- Enigma. Agile, stubborn and sensitive villain. Puzzled Batman. Prepared toxins.
- Mr. Frieze . Agile, moderate and cold-blooded villain. He wanted to freeze Gotham.
Others
- Fighters of Mr. Freeze and the Riddler .
- Residents of Gotham .
Notes
- ↑ Overview - Batman: Toxic Chill . allgame . Date of treatment January 20, 2010.